Celgene, Actavis Among 4 Top-Rated Big-Cap Drugmakers

By | December 4, 2013

Scalper1 News

Drugmakers Celgene (CELG) and Biogen Idec (BIIB) are among four big-cap drugmakers with deep pockets and proven product lines and processes. Today’s Screen Of The Day is Big Cap Leaders, top-rated large-cap stocks priced above 15. The four drugmakers on the Big Cap Leaders list include biotechs Celgene and Biogen Idec as well as generic drugmakers Actavis (ACT) and Perrigo (PRGO). Celgene and Actavis are also on the proprietary IBD Leaderboard Scalper1 News

Scalper1 News